Epic Aesthetic Medical Institute Inc. | |
11349 Saticoy St Sun Valley CA 91352-4700 | |
(818) 982-5750 | |
(818) 982-9146 |
Full Name | Epic Aesthetic Medical Institute Inc. |
---|---|
Speciality | General Practice |
Location | 11349 Saticoy St, Sun Valley, California |
Authorized Official Name and Position | Jasmin Javaherian (OWNER) |
Authorized Official Contact | 8185013366 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
Epic Aesthetic Medical Institute Inc. 16661 Ventura Blvd Suite 815 Encino CA 91436-1914 Ph: (818) 501-3366 | Epic Aesthetic Medical Institute Inc. 11349 Saticoy St Sun Valley CA 91352-4700 Ph: (818) 982-5750 |
NPI Number | 1962702167 |
---|---|
Provider Enumeration Date | 10/22/2010 |
Last Update Date | 05/16/2014 |
Medicare PECOS PAC ID | 3779706965 |
---|---|
Medicare Enrollment ID | O20140515000430 |
News Archive
Takeda Pharmaceutical Company Limited and Natrogen Therapeutics International, Inc. jointly announced today an agreement whereby Takeda will acquire an exclusive license to develop Natrogen's Natura-alpha compound as well as an option to acquire Natrogen. Natura-alpha is a synthetic small molecule oral compound that is believed to inhibit pro-inflammatory cytokine expression, which may help to reduce gastrointestinal inflammation. Natura-alpha is currently in Phase 2 development for the treatment of ulcerative colitis.
The US E-Prescription Systems market is forecast to reach $204.67 million, while the European market is forecast to reach $508.38 million by the year 2017, according to a new report on companiesandmarkets.com.
Please be advised that Gallup and Healthways, Inc. today released the Gallup-Healthways Monthly U.S. Well-Being Report for November 2009.
Gastroesophageal reflux, defined as passage of gastric contents into the esophagus is a normal process that occurs in healthy infants, children and adults. When GER causes troublesome symptoms and/or complications it is referred to as gastroesophageal reflux disease. During infancy, GER is common and can manifest with specific symptoms as vomiting and non-specific symptoms as irritability and cough. Association of non-specific symptoms with GER is a main problem in the diagnosis of GERD.
Normal hearing depends on the presence of healthy hair cells in the inner ear. Gene therapy has the potential to slow the loss of hair cells and promote the growth of hair cells that have already been damaged.
› Verified 7 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1962702167 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | 20A8083 (California) | Primary |
Provider Name | Jasmin Javaherian |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1447294715 PECOS PAC ID: 6103850953 Enrollment ID: I20050921001057 |
News Archive
Takeda Pharmaceutical Company Limited and Natrogen Therapeutics International, Inc. jointly announced today an agreement whereby Takeda will acquire an exclusive license to develop Natrogen's Natura-alpha compound as well as an option to acquire Natrogen. Natura-alpha is a synthetic small molecule oral compound that is believed to inhibit pro-inflammatory cytokine expression, which may help to reduce gastrointestinal inflammation. Natura-alpha is currently in Phase 2 development for the treatment of ulcerative colitis.
The US E-Prescription Systems market is forecast to reach $204.67 million, while the European market is forecast to reach $508.38 million by the year 2017, according to a new report on companiesandmarkets.com.
Please be advised that Gallup and Healthways, Inc. today released the Gallup-Healthways Monthly U.S. Well-Being Report for November 2009.
Gastroesophageal reflux, defined as passage of gastric contents into the esophagus is a normal process that occurs in healthy infants, children and adults. When GER causes troublesome symptoms and/or complications it is referred to as gastroesophageal reflux disease. During infancy, GER is common and can manifest with specific symptoms as vomiting and non-specific symptoms as irritability and cough. Association of non-specific symptoms with GER is a main problem in the diagnosis of GERD.
Normal hearing depends on the presence of healthy hair cells in the inner ear. Gene therapy has the potential to slow the loss of hair cells and promote the growth of hair cells that have already been damaged.
› Verified 7 days ago
News Archive
Takeda Pharmaceutical Company Limited and Natrogen Therapeutics International, Inc. jointly announced today an agreement whereby Takeda will acquire an exclusive license to develop Natrogen's Natura-alpha compound as well as an option to acquire Natrogen. Natura-alpha is a synthetic small molecule oral compound that is believed to inhibit pro-inflammatory cytokine expression, which may help to reduce gastrointestinal inflammation. Natura-alpha is currently in Phase 2 development for the treatment of ulcerative colitis.
The US E-Prescription Systems market is forecast to reach $204.67 million, while the European market is forecast to reach $508.38 million by the year 2017, according to a new report on companiesandmarkets.com.
Please be advised that Gallup and Healthways, Inc. today released the Gallup-Healthways Monthly U.S. Well-Being Report for November 2009.
Gastroesophageal reflux, defined as passage of gastric contents into the esophagus is a normal process that occurs in healthy infants, children and adults. When GER causes troublesome symptoms and/or complications it is referred to as gastroesophageal reflux disease. During infancy, GER is common and can manifest with specific symptoms as vomiting and non-specific symptoms as irritability and cough. Association of non-specific symptoms with GER is a main problem in the diagnosis of GERD.
Normal hearing depends on the presence of healthy hair cells in the inner ear. Gene therapy has the potential to slow the loss of hair cells and promote the growth of hair cells that have already been damaged.
› Verified 7 days ago
Boydar Md Group Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 8730 Glenoaks Blvd, Sun Valley, CA 91352 Phone: 818-960-7171 Fax: 818-960-7177 | |
Serra Community Medical Clinic- Sunland Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 8426 Sunland Blvd, Sun Valley, CA 91352 Phone: 818-504-4526 Fax: 818-504-4690 | |
Family Care Md Group Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 8730 Glenoaks Blvd, Sun Valley, CA 91352 Phone: 818-960-7171 Fax: 818-960-7177 | |
Medlink Prestige Group Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 8730 Glenoaks Blvd # 4, Sun Valley, CA 91352 Phone: 818-960-7171 Fax: 818-960-7177 | |
Joon Choi Md A Professional Corporation Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 8100 Sunland Blvd, Sun Valley, CA 91352 Phone: 818-242-6811 | |
Elevate Health Center Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 8426 Sunland Blvd, Sun Valley, CA 91352 Phone: 818-504-4514 Fax: 747-245-1096 | |
Glenoaks Medical Care Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 8730 Glenoaks Blvd, Sun Valley, CA 91352 Phone: 818-767-8811 |